Please assess the completion status of the following clinical trial:

Trial Title: Treatment of Nasal Airway Obstruction Using the Aerin Medical Device

Study Design Characteristics:
- Allocation: None
- Intervention Model: SINGLE_GROUP
- Observational Model: None
- Primary Purpose: TREATMENT
- Time Perspective: None
- Masking: NONE
- Phase: None
- Number of Arms: 1.0

Eligibility Criteria:
Inclusion Criteria:~* Seeking treatment for nasal obstruction and willing to undergo an office-based procedure~* Nasal Obstruction Symptom Evaluation (NOSE) score of ≥ 60 at Baseline~* Nasal valve is a primary or significant contributor to the subject's nasal obstruction as determined by the study investigator (based on clinical presentation, physical examination, nasal endoscopy, etc.) and the subject has a positive response to any of the following temporary measures (based on patient history or office exam):~* Use of external nasal dilator strips (e.g., Breathe Right Strips)~* Q-Tip test (manual intranasal lateralization)~* Use of nasal stents~* Cottle Maneuver (manual lateral retraction of the cheek)~Exclusion Criteria:~* Prior surgical treatment of the nasal valve~* Rhinoplasty, septoplasty, inferior turbinate reduction or other surgical nasal procedures within the past twelve (12) months~* Chronic sinusitis, recurrent sinusitis, or allergies leading to nasal obstruction~* Septal deviation, turbinate hypertrophy, polyps, or ptotic nose tip believed to be a significant contributor to the subject's nasal obstruction symptoms~* Known or suspected allergies or contraindications for any general or local anesthetic agents and / or any antibiotic medications~* Known or suspected to be pregnant, or is lactating~* Other medical conditions which in the opinion of the investigator could predispose the subject to poor wound healing or increased surgical risk

- Gender: ALL
- Minimum Age: 22 Years
- Maximum Age: 75 Years
- Healthy Volunteers: f

Study Arms:
- Vivaer Stylus (Type: EXPERIMENTAL): Intervention: Procedure: thermal treatment of submucosal tissue including cartilage in the internal nasal valve area

Based on this trial design, predict the completion outcome and termination type (if applicable).